WEYERHAEUSER CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WEYERHAEUSER CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.91B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.12B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $7.67B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $10.18B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $10.20B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $7.53B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $1.55B | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $1.67B | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $1.69B | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $1.64B | Feb 14, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.82B | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | $1.87B | Feb 16, 2018 |
| FY2017 | Jun 30, 2017 | $1.81B | Feb 16, 2018 |
| FY2017 | Mar 31, 2017 | $1.69B | Feb 16, 2018 |
| FY2016 | Dec 31, 2016 | $1.60B | Feb 24, 2017 |
| FY2016 | Sep 30, 2016 | $1.71B | Feb 24, 2017 |
| FY2016 | Jun 30, 2016 | $1.66B | Feb 24, 2017 |
| FY2016 | Mar 31, 2016 | $1.41B | Feb 24, 2017 |
| FY2015 | Dec 31, 2015 | $1.73B | Feb 17, 2016 |
| FY2015 | Sep 30, 2015 | $1.82B | Feb 17, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.31B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.68B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $3.62B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $4.10B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $2.09B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.14B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.88B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.90B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $1.39B | Feb 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $324.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $396.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $839.00M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.88B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.61B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $797.00M | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | ($14.00M) | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $99.00M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $128.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | ($289.00M) | Feb 14, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $731.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $685.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.19B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $3.08B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.64B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.71B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $89.00M | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | $202.00M | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | $186.00M | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | $174.00M | Feb 14, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $7.00M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $6.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $5.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $5.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $6.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $8.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $14.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $19.00M | Feb 15, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $601.00M | Feb 22, 2012 |
| FY2011 | Dec 31, 2010 | $650.00M | Feb 22, 2012 |
| FY2011 | Dec 31, 2009 | $681.00M | Feb 22, 2012 |
| FY2010 | Dec 31, 2008 | $996.00M | Feb 25, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $562.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.43B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $2.83B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.16B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.53B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $966.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.11B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $735.00M | Feb 15, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $368.00M | Feb 15, 2019 |
| FY2017 | Dec 31, 2017 | $358.00M | Feb 16, 2018 |
| FY2016 | Dec 31, 2016 | $451.00M | Feb 24, 2017 |
| FY2015 | Dec 31, 2015 | $443.00M | Feb 17, 2016 |
| FY2014 | Dec 31, 2014 | $354.00M | Feb 13, 2015 |
| FY2013 | Dec 31, 2013 | $261.00M | Feb 18, 2014 |
| FY2012 | Dec 31, 2012 | $256.00M | Feb 19, 2013 |
| FY2011 | Dec 31, 2011 | $212.00M | Feb 22, 2012 |
| FY2011 | Dec 31, 2010 | $194.00M | Feb 22, 2012 |
| FY2011 | Dec 31, 2009 | $187.00M | Feb 22, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.61B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $16.54B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $16.98B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $17.34B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $17.65B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $16.31B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $16.41B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $17.25B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $18.06B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $19.24B | Feb 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.19B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.82B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.75B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $6.59B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $6.89B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $7.58B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $8.23B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $8.20B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $9.16B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $10.06B | Feb 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.43B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $9.72B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $10.24B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $10.75B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $10.77B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $8.73B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $8.18B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $9.05B | Feb 19, 2021 |
| FY2015 | Dec 31, 2015 | $4.87B | Feb 17, 2016 |
| FY2015 | Dec 31, 2014 | $5.30B | Feb 17, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $40.00M | Feb 16, 2018 |
| FY2016 | Dec 31, 2016 | $40.00M | Feb 24, 2017 |
| FY2015 | Dec 31, 2015 | $40.00M | Feb 17, 2016 |
| FY2014 | Dec 31, 2014 | $40.00M | Feb 13, 2015 |
| FY2013 | Dec 31, 2013 | $42.00M | Feb 18, 2014 |
| FY2013 | Dec 31, 2012 | $40.00M | Feb 18, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.43B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.72B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.01B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.39B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.13B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $411.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | ($3.00M) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.09B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $1.08B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $1.42B | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $464.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $684.00M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.16B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $1.58B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.88B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $495.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $139.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $334.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $824.00M | Feb 15, 2019 |
| FY2018 | Dec 31, 2016 | $676.00M | Feb 15, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.08B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.07B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $5.05B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $5.10B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $5.48B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $6.15B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $5.92B | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.99B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.61B | Feb 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 14, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 18, 2022 |
| FY2018 | Dec 31, 2018 | 0 | Feb 15, 2019 |
| FY2017 | Dec 31, 2017 | 0 | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Feb 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 720.53M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 725.85M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 729.75M | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | 732.79M | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | 747.30M | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | 747.39M | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | 745.30M | Feb 17, 2023 |
| FY2021 | Dec 31, 2018 | 746.39M | Feb 18, 2022 |
| FY2020 | Dec 31, 2017 | 755.22M | Feb 19, 2021 |
| FY2019 | Dec 31, 2016 | 748.53M | Feb 14, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $606.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $684.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.62B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $884.00M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $381.00M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $1.01B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $995.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $941.00M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $932.00M | Feb 15, 2019 |